Proposed Data Collection Submitted for Public Comment and Recommendations, 79925-79926 [2024-22474]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices
79925
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Number of
respondents
Number of
responses
per
respondent
Average
burden per
response
(in hours)
...........................................................
........................
........................
........................
Type of respondents
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–22475 Filed 9–30–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–24–24IV; Docket No. CDC–2024–
0071]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled
‘‘Comprehensive Evaluation of the
Implementation and Uptake of the CDC
Clinical Practice Guideline for
Prescribing Opioids for Pain’’. This data
collection is designed to allow CDC to
evaluate the 2022 CDC Clinical Practice
Guidelines for opioid prescription
practices.
SUMMARY:
CDC must receive written
comments on or before December 2,
2024.
DATES:
You may submit comments,
identified by Docket No. CDC–2024–
0071 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:42 Sep 30, 2024
Jkt 265001
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, H
21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Total
burden
(in hours)
2,334
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Comprehensive Evaluation of the
Implementation and Uptake of the CDC
Clinical Practice Guideline for
Prescribing Opioids for Pain—New—
National Center for Injury Prevention
and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Beginning in the 1990s, opioid
prescribing rates for pain management
steadily increased until 2010, remained
steady until 2012, and have declined
since then. The increase in opioid
prescribing rates corresponded with
increases in opioid-involved overdose
deaths, which initially primarily
involved prescription opioids (natural
and semi-synthetic opioids and
methadone). In response to this
emerging crisis, CDC issued the CDC
Guideline for Prescribing Opioids for
Chronic Pain—United States, 2016
(2016 CDC Guideline). Implementing
the 2016 CDC Guideline was associated
with reductions in opioid prescribing
and increases in use of non-opioid
medications for pain. At the same time,
laws and policies related to prescribing
opioids were instituted that misapplied
or were inconsistent with the 2016 CDC
Guideline, potentially contributing to
patient harm. In 2022, CDC released the
CDC Clinical Practice Guideline for
Prescribing Opioids for Pain—United
States, 2022, which provided up to date
evidence regarding pain management
approaches and re-emphasizes the need
for prescribers to be focused on patientcentered care to provide effective pain
management. CDC is comprehensively
evaluating the uptake, implementation,
and outcomes of the 2022 CDC Clinical
Practice Guideline on evidence-based
care for pain management to understand
its impact.
E:\FR\FM\01OCN1.SGM
01OCN1
79926
Federal Register / Vol. 89, No. 190 / Tuesday, October 1, 2024 / Notices
To meet CDC’s goal for a rigorous,
comprehensive evaluation, this
collection is proposing a mixed-method
quasi-experimental design with the
following three aims to evaluate the
2022 CDC Clinical Practice Guideline:
• Aim 1: Dissemination—Assess
CDC’s efforts in disseminating the 2022
CDC Clinical Practice Guideline.
• Aim 2: Impact—Evaluate the impact
of the 2022 CDC Clinical Practice
Guideline through population-wide
changes in prescribing practices for
opioids and medications for opioid use
disorder.
• Aim 3: Implementation—Evaluate
the implementation of the 2022 CDC
Number of
respondents
interviews with dentists, virtual
interviews with leaders from
professional organizations, payers,
medical boards, and health systems, and
virtual focus groups with patients and
caregivers.
The CDC will use this information
collection to evaluate the dissemination,
impact, and implementation of the 2022
CDC Clinical Practice Guideline to
ensure that Americans have access to
safer, effective ways of managing their
pain. CDC requests OMB approval for an
estimated 325 annual burden hours.
There is no cost to respondents other
than their time.
Estimated Annualized Burden Hours
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Type of respondents
Form name
Clinicians ...........................................
200
1,000
1,000
10
2
3
3
3
1
1
1
1
1
2
2
2
10/60
5/60
5/60
1
1
1
1
1
33
83
83
10
2
6
6
6
Medical Board Leaders .....................
Patients .............................................
Caregivers .........................................
Clinician Survey ...............................
Invitation ...........................................
Follow up Emails ..............................
Clinician Interview ............................
Dentist Interview ...............................
Health System Leaders Interview ....
Payer Interview ................................
Professional Association Leaders
Interview.
Medical Board Leaders Interview ....
Patient Focus Groups ......................
Caregiver Focus Groups ..................
3
15
15
2
3
2
1
1
1
6
45
30
Total ...........................................
...........................................................
........................
........................
........................
325
Dentists .............................................
Health System Leaders ....................
Payers ...............................................
Professional Association Leaders .....
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–22474 Filed 9–30–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–24–24AL]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKJM1Z7X2PROD with NOTICES
Clinical Practice Guideline from
perspectives of patients, caregivers,
clinicians; and leaders from health
systems, payers, professional
associations, and medical boards.
This evaluation will include
systematic collection and analysis of a
range of primary and secondary data
sources. To answer the research
questions, we will employ qualitative
synthesis and analytic approaches,
quantitative analyses, and various
mixed-methods approaches. Primary
data collection efforts include a webbased survey conducted among a
national sample of clinicians, virtual
interviews with clinicians, virtual
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Occupational
Exposures to Surgical Smoke in
Veterinary Personnel’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on November
VerDate Sep<11>2014
17:42 Sep 30, 2024
Jkt 265001
3, 2023 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Occupational Exposures to Surgical
Smoke in Veterinary Personnel—New—
National Institute for Occupational
E:\FR\FM\01OCN1.SGM
01OCN1
]]>Agencies
[Federal Register Volume 89, Number 190 (Tuesday, October 1, 2024)]
[Notices]
[Pages 79925-79926]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-22474]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-24-24IV; Docket No. CDC-2024-0071]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled ``Comprehensive Evaluation of the Implementation and Uptake of
the CDC Clinical Practice Guideline for Prescribing Opioids for Pain''.
This data collection is designed to allow CDC to evaluate the 2022 CDC
Clinical Practice Guidelines for opioid prescription practices.
DATES: CDC must receive written comments on or before December 2, 2024.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-
0071 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, H 21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Comprehensive Evaluation of the Implementation and Uptake of the
CDC Clinical Practice Guideline for Prescribing Opioids for Pain--New--
National Center for Injury Prevention and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Beginning in the 1990s, opioid prescribing rates for pain
management steadily increased until 2010, remained steady until 2012,
and have declined since then. The increase in opioid prescribing rates
corresponded with increases in opioid-involved overdose deaths, which
initially primarily involved prescription opioids (natural and semi-
synthetic opioids and methadone). In response to this emerging crisis,
CDC issued the CDC Guideline for Prescribing Opioids for Chronic Pain--
United States, 2016 (2016 CDC Guideline). Implementing the 2016 CDC
Guideline was associated with reductions in opioid prescribing and
increases in use of non-opioid medications for pain. At the same time,
laws and policies related to prescribing opioids were instituted that
misapplied or were inconsistent with the 2016 CDC Guideline,
potentially contributing to patient harm. In 2022, CDC released the CDC
Clinical Practice Guideline for Prescribing Opioids for Pain--United
States, 2022, which provided up to date evidence regarding pain
management approaches and re-emphasizes the need for prescribers to be
focused on patient-centered care to provide effective pain management.
CDC is comprehensively evaluating the uptake, implementation, and
outcomes of the 2022 CDC Clinical Practice Guideline on evidence-based
care for pain management to understand its impact.
[[Page 79926]]
To meet CDC's goal for a rigorous, comprehensive evaluation, this
collection is proposing a mixed-method quasi-experimental design with
the following three aims to evaluate the 2022 CDC Clinical Practice
Guideline:
Aim 1: Dissemination--Assess CDC's efforts in
disseminating the 2022 CDC Clinical Practice Guideline.
Aim 2: Impact--Evaluate the impact of the 2022 CDC
Clinical Practice Guideline through population-wide changes in
prescribing practices for opioids and medications for opioid use
disorder.
Aim 3: Implementation--Evaluate the implementation of the
2022 CDC Clinical Practice Guideline from perspectives of patients,
caregivers, clinicians; and leaders from health systems, payers,
professional associations, and medical boards.
This evaluation will include systematic collection and analysis of
a range of primary and secondary data sources. To answer the research
questions, we will employ qualitative synthesis and analytic
approaches, quantitative analyses, and various mixed-methods
approaches. Primary data collection efforts include a web-based survey
conducted among a national sample of clinicians, virtual interviews
with clinicians, virtual interviews with dentists, virtual interviews
with leaders from professional organizations, payers, medical boards,
and health systems, and virtual focus groups with patients and
caregivers.
The CDC will use this information collection to evaluate the
dissemination, impact, and implementation of the 2022 CDC Clinical
Practice Guideline to ensure that Americans have access to safer,
effective ways of managing their pain. CDC requests OMB approval for an
estimated 325 annual burden hours. There is no cost to respondents
other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Clinicians.................... Clinician Survey 200 1 10/60 33
Invitation...... 1,000 1 5/60 83
Follow up Emails 1,000 1 5/60 83
Clinician 10 1 1 10
Interview.
Dentists...................... Dentist 2 1 1 2
Interview.
Health System Leaders......... Health System 3 2 1 6
Leaders
Interview.
Payers........................ Payer Interview. 3 2 1 6
Professional Association Professional 3 2 1 6
Leaders. Association
Leaders
Interview.
Medical Board Leaders......... Medical Board 3 2 1 6
Leaders
Interview.
Patients...................... Patient Focus 15 3 1 45
Groups.
Caregivers.................... Caregiver Focus 15 2 1 30
Groups.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 325
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-22474 Filed 9-30-24; 8:45 am]
BILLING CODE 4163-18-P
